Zymeworks, Inc. (ZYME)
23.62
+0.63
(+2.74%)
USD |
NASDAQ |
Feb 24, 16:00
23.62
0.00 (0.00%)
After-Hours: 18:53
Zymeworks Total Liabilities (Quarterly) : 77.20M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Vertex Pharmaceuticals, Inc. | 7.477B |
| BioLife Solutions, Inc. | 38.34M |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 397.27M |
| Shareholders Equity (Quarterly) | 320.06M |
| Debt to Equity Ratio | 0.0591 |
| Current Ratio | 6.938 |
| Net Debt Paydown Yield | 0.02% |